 |
 |
 |
 |
 |
 |
||
 |
 |
 |
 |
 |
| 5 | 1/1 | 返回列表 |
| 查看: 1643 | 回復(fù): 7 | |||
| 當(dāng)前只顯示滿足指定條件的回帖，點擊這里查看本話題的所有回帖 | |||
如貓似狗金蟲 (正式寫手)
|
[交流]
一篇中藥成分活性的綜述英文手稿sci秒拒11回還有什么期刊可推薦試試？ 已有2人參與
|
||
|
大概1萬字。拒稿11次，都沒送審過，想再找一個sci期刊試試，如果還不行就打算試投普刊了。 1.ARCHIV DER PHARMAZIE，IF5.1，免費，年文章數(shù)164，rejected 2. PHYTOTHERAPY RESEARCH，IF7.2，免費，年文章數(shù)323，rejected 3.Fitoterapia，IF3.4，免費，年文章數(shù)214，收綜述，rejected 4.Planta medica，拒稿 5.Phytomedicine，拒稿 6.Journal of TCM，拒稿 7.Frontier in pharmacology，拒稿，文中引文是作者年，文獻列表是作者字母順序 8.CNMJ, 拒稿，文中引文是數(shù)字，文獻列表也是數(shù)字 9.Applied Sciences，拒稿，文中引文是數(shù)字，文獻列表也是數(shù)字 10.Journal of Ethnopharmacology，拒稿 11.The American Journal of Chinese Medicine，拒稿 |
回復(fù)此樓» 猜你喜歡
研究生招生
已經(jīng)有6人回復(fù)
-
材料與化工，291，求調(diào)劑
已經(jīng)有12人回復(fù)
-
0817一志愿蘇州大學(xué)280復(fù)試調(diào)劑
已經(jīng)有8人回復(fù)
-
求調(diào)劑 一志愿蘇州大學(xué)，0856化工323分 | 本科應(yīng)化 | 有專利/競賽/科研助手經(jīng)歷 |
已經(jīng)有9人回復(fù)
-
085602化工求調(diào)劑
已經(jīng)有4人回復(fù)
-
083000環(huán)境科學(xué)與工程調(diào)劑
已經(jīng)有6人回復(fù)
-
307求調(diào)劑
已經(jīng)有3人回復(fù)
-
求材料讀博院校
已經(jīng)有9人回復(fù)
-
哈工大材料324求調(diào)劑
已經(jīng)有4人回復(fù)
-
材料調(diào)劑，307分
已經(jīng)有10人回復(fù)
TopEdit
銅蟲 (著名寫手)
- 應(yīng)助: 184 (高中生)
- 金幣: 4223
- 帖子: 1111
- 在線: 32.2小時
- 蟲號: 35566815
- 注冊: 2024-08-01
- 專業(yè): 食品科學(xué)基礎(chǔ)
8樓2024-11-28 10:56:48
linjunc
金蟲 (正式寫手)
- 應(yīng)助: 0 (幼兒園)
- 金幣: 1266.6
- 帖子: 578
- 在線: 17.6小時
- 蟲號: 33613141
- 注冊: 2023-04-16
- 專業(yè): 太陽和太陽系
2樓2024-11-22 20:26:01
TopEdit
銅蟲 (著名寫手)
- 應(yīng)助: 184 (高中生)
- 金幣: 4223
- 帖子: 1111
- 在線: 32.2小時
- 蟲號: 35566815
- 注冊: 2024-08-01
- 專業(yè): 食品科學(xué)基礎(chǔ)
3樓2024-11-25 13:49:38
如貓似狗
金蟲 (正式寫手)
- 應(yīng)助: 20 (小學(xué)生)
- 金幣: 2312.9
- 散金: 170
- 紅花: 3
- 帖子: 521
- 在線: 214.7小時
- 蟲號: 1177656
- 注冊: 2010-12-26
- 性別: GG
- 專業(yè): 天然有機化學(xué)
|
就Frontier in pharmacology給了些意見，我粘上來：The reason for this decision is: The content of this manuscript does not meet the standards of scientific quality or rigor required by the journal to be considered for peer review.質(zhì)量和嚴(yán)謹(jǐn)性不過關(guān) Thank you for this MS手稿, which certainly 當(dāng)然，無疑is within our scope and potentially interesting. However, the review process has identified a series of further concerns. 綜述過程有問題，有大問題There are major concerns and therefore, we cannot send your MS our to peer-review and we must reject your MS. The AE副編輯 highlighted: In its current form the MS in essence descriptive and a more critical analysis of the evidence. @@@現(xiàn)在手稿是描述性的，應(yīng)該更加批判性的。What do the data you review show and what not 文獻給出什么，沒有給出什么(i.e. limitations, problems in the design of the studies and future research needs? @@@實驗設(shè)計的局限性和問題是什么？將來研究方向？Please note: @@@If pharmacological studies are reviewed, we expect some information on the dose range tested劑量范圍, the minimal active concentration最小有效濃度, the model used (incl. information whether it is an in vitro or in vivo study), if and what controls (incl positive and negative陽性對照和陰性對照) were used, duration, type of extract used as well as other basic pharmacological data. The same is in essence true for clinical studies. Often pharmacological activities are reported very naively天真和幼稚，有些paper爛, and such papers are especially common in journals with no or poor peer-review. This ranges from simple points like a use of appropriate controls and the full taxonomic validity分類學(xué)有效性 of the material under investigation (see also below), to the relevance of the model模型與所研究問題相關(guān)性 for the question being researched (e.g. can specific in silico or in vitro models really say s.th. about the species anti-inflammatory activity?例如計算機模擬或者體外模型能夠說明物種的抗炎活性嗎). Reviews must provide a specific and critical (!!) assessment of the literature. 綜述必須對文獻進行具體和批判性的（！�。┰u估。The scientific quality of the original articles must be critically assessed. 文獻的質(zhì)量必須嚴(yán)格評估。This includes the experimental design, and reliability of the studies研究的可靠性including a sufficiently detailed definition of the material under investigation. A description of the limitations and future research needs and priorities優(yōu)先事項，當(dāng)務(wù)之急 must be included.必須包括對局限性和未來研究需求和優(yōu)先事項的描述。 |
4樓2024-11-27 16:10:40
| 最具人氣熱帖推薦 [查看全部] | 作者 | 回/看 | 最后發(fā)表 | |
|---|---|---|---|---|
|
[考研] 085602化工求調(diào)劑 +4 | 董boxing 2026-03-10 | 4/200 |
|
|---|---|---|---|---|
|
|
[考研] 一志愿山東大學(xué)105500藥學(xué)專碩，總分302求調(diào)劑 +5 | 五維天空 2026-03-04 | 12/600 |
|
|
[考研] 新疆大學(xué)地質(zhì)與礦業(yè)工程學(xué)院招生 +24 | another12 2026-03-04 | 32/1600 |
|
|
|
[考研] 293求調(diào)劑 +4 | 上班不著吉 2026-03-09 | 4/200 |
|
|
|
[基金申請] 第二個面上項目的獲批幾率如何？ +3 | wawm9296 2026-03-04 | 5/250 |
|
|
|
[考研] 0817找調(diào)劑 +6 | kk扛 2026-03-08 | 6/300 |
|
|
|
[考研] 一志愿中科大能動297求調(diào)劑，本科川大 +4 | 邵11 2026-03-03 | 4/200 |
|
|
|
[考研] 322分 085600求調(diào)劑，有互聯(lián)網(wǎng)+國金及主持省級大創(chuàng)經(jīng)歷 +4 | 熊境喆 2026-03-05 | 4/200 |
|
|
|
[考研] 誠求調(diào)劑，323分 有專利/科研/實習(xí)經(jīng)歷 +6 | 橙子cyx 2026-03-06 | 8/400 |
|
|
|
[考研] 一志愿哈爾濱工業(yè)大學(xué)0856材料與化工，前三科206，總分283，求調(diào)劑 +7 | 26考研求調(diào)劑 2026-03-06 | 7/350 |
|
|
|
[考研] 085600，一志愿鄭州大學(xué)，280分求調(diào)劑 +7 | Wuqi725 2026-03-05 | 7/350 |
|
|
|
[考研] 274求調(diào)劑 +9 | 一個學(xué)習(xí)者 2026-03-04 | 9/450 |
|
|
|
[考研] 求材料調(diào)劑 +4 | berdmond 2026-03-05 | 4/200 |
|
|
|
[考研] 0856材料專碩274能調(diào)劑去哪里？ +3 | 22735 2026-03-04 | 4/200 |
|
|
|
[考研] 材料學(xué)碩080500復(fù)試調(diào)劑294 +3 | 四葉zjz 2026-03-04 | 3/150 |
|
|
|
[考研] 0703化學(xué) 一志愿東北大學(xué) 279分求調(diào)劑 +4 | 聶樂平 2026-03-03 | 4/200 |
|
|
|
[考研] 295求調(diào)劑 +4 | 小賽不吃香菜 2026-03-04 | 4/200 |
|
|
|
[考研] 0857求調(diào)劑 +4 | CDDD1013 2026-03-04 | 4/200 |
|
|
|
[考研] 281求調(diào)劑 +3 | 我是小小蔥蔥 2026-03-03 | 5/250 |
|
|
|
[考研] 281求調(diào)劑 +3 | Y?l?h 2026-03-04 | 3/150 |
|